Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation.
about
TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival.Therapy-related myeloid neoplasms: pathobiology and clinical characteristicsRisk of myeloid neoplasms after solid organ transplantation.Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant.The pros and the cons of mTOR inhibitors in kidney transplantation.Blood disorders typically associated with renal transplantationIncreased risk for lymphoid and myeloid neoplasms in elderly solid-organ transplant recipients.Evolutionarily conserved genetic interactions with budding and fission yeast MutS identify orthologous relationships in mismatch repair-deficient cancer cells.6-Thioguanine and S⁶-methylthioguanine are mutagenic in human cellsDo inflammatory bowel disease therapies cause cancer?Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer.Reactivity against microsatellite instability-induced frameshift mutations in patients with inflammatory bowel disease.Microsatellite alterations are also present in the less aggressive types of adult T-cell leukemia-lymphomaTherapy-related myeloid neoplasms following treatment with radioiodine.Acute myeloid leukemia developing in patients with autoimmune diseases.What is wrong with Fanconi anemia cells?Azathioprine induction of tumors with microsatellite instability: risk evaluation using a mouse model.Establishment and characterization of HROC69 - a Crohn´s related colonic carcinoma cell line and its matched patient-derived xenograft.Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia.Therapy-related myeloid leukemia.The role of DNA damage repair in aging of adult stem cellsAcute leukemia as a secondary malignancy in children and adolescents: current findings and issues.Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease.Therapy-related myeloid neoplasms.Commentary: does immune suppression increase risk of developing acute myeloid leukemia?Multiple forms of DNA damage caused by UVA photoactivation of DNA 6-thioguanine.A case of therapy-related myeloid neoplasm in a patient with Crohn's disease treated with azathioprine.Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Myeloid Leukemia following Orthotopic Cardiac TransplantationManagement of the elderly patients with inflammatory bowel disease: practical considerations.Acute myeloid leukemia following solid organ transplantation: entity or novelty?Skin cancer in kidney transplant recipients.Therapy-related myeloid neoplasms: when genetics and environment collide.Oxidatively-generated damage to DNA and proteins mediated by photosensitized UVALoss of p300 accelerates MDS-associated leukemogenesis.Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort.Mechanistic mathematical modelling of mercaptopurine effects on cell cycle of human acute lymphoblastic leukaemia cells.Immunosuppressant-driven de novo malignant neoplasms after solid-organ transplant.Microsatellite instability in hematological malignancies: Hypermutation vs. immune control-who is challenging who?Myeloid Neoplasms Following Solid Organ Transplantation: Clinicopathologic Studies of 23 Cases.Outcomes of patients diagnosed with acute myeloid leukemia after solid organ transplantation.
P2860
Q24812743-D021C153-FCB0-4435-B90D-C315371ED96EQ28386366-14D24ECF-F947-402C-81BC-2B73B997A05EQ30592352-1A39B208-80FA-4615-843A-3B3D65A52782Q33390055-80F18D72-B974-4AEF-AD95-1A3CD4975FBCQ33412367-D1210981-C467-451E-83C5-B337BC183B62Q33421793-19C2E162-EF8B-4BEF-8606-44399E0E9E41Q33835631-AB7940A9-2D81-4791-A7A3-DC240854D31AQ34306599-93A4997C-5D8B-4192-A4B8-02A50BF407D4Q34440523-EAA3B033-79F7-41FA-B4C1-F20DF22DE189Q34613890-58A64A8D-6609-4643-8F6E-D7538D6101FFQ34728470-E9526D2D-6A42-4390-B60E-5173B9A55200Q34827304-1E1A69F2-1709-4700-ACEC-5B4A2FFCE86AQ34973025-18758CFD-65FD-427C-949D-C8F9E43F7CE5Q35717790-4D54F215-E4C7-467E-9772-0EE7975ACF34Q36006358-8ADA3AE8-BB2F-4E72-8ABE-6E724ED220D5Q36186819-730F70D8-DEE2-468D-83EC-C54F5939876BQ36413082-82A65470-A9BE-4AD5-A9C6-0D8F32F77D3FQ36806403-40DBE438-7765-487A-BC92-A9206636CFC2Q36835902-A2376B7D-13D5-409E-BA5E-D43E429E5C24Q37009760-C497A161-9923-4138-93DB-C899388A01D3Q37045395-DC8BFE48-8D59-490F-B113-191E81E60225Q37346340-140742EE-D35B-44F4-ADC1-261F0933DC87Q37358453-C5121C14-84EE-49D0-AC52-4B1C29545352Q37428433-B5AECFDA-0AF7-47FC-B647-54E2DA12FE44Q37922582-3D549A06-16EB-4566-9861-2CFE9BB84310Q37955182-D86922CF-9CCD-437C-A4CB-556EB8818C41Q38008808-2689BF47-13D8-42DF-8D5D-992AC4D7E3F7Q38100792-92C4A2F1-7965-4FCB-B16C-F56E24888308Q38122069-1DF91A91-7F39-492D-BA2A-304EF87D4EF8Q38188011-5D293A7F-860B-4E54-9DFC-567D5ABE5243Q38210273-8C67E483-12F4-4026-93AE-8CE13A053B0AQ38611096-71B700A6-1586-4BCE-AFF3-F99CB31310C2Q39042732-28A177AB-121D-48E1-88DB-0AB7812639FBQ39157705-5A3BBFAF-85F6-441F-BB47-2BB6560A992AQ39773210-B0DE80A0-1AC3-4C0E-888C-F818E2298E06Q40342697-1966490C-17C5-44DD-B56F-A7BE9B9C57F2Q41645033-E06D0714-6A55-4FFC-A455-9EDFD0A48CB7Q42937984-A2F1922E-8A08-494C-9959-7EC8FEFF57D1Q46402491-BFD286AC-1D8E-4400-9BA0-F1D24BA8E3C8Q48121295-586FBE18-AA9F-42EA-A96E-B0EB59E53F72
P2860
Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Defective DNA mismatch repair ...... e after organ transplantation.
@en
Defective DNA mismatch repair ...... e after organ transplantation.
@nl
type
label
Defective DNA mismatch repair ...... e after organ transplantation.
@en
Defective DNA mismatch repair ...... e after organ transplantation.
@nl
prefLabel
Defective DNA mismatch repair ...... e after organ transplantation.
@en
Defective DNA mismatch repair ...... e after organ transplantation.
@nl
P2093
P1433
P1476
Defective DNA mismatch repair ...... e after organ transplantation.
@en
P2093
Bernd Doehler
David Cummins
Dianne Sullivan
Judith Offman
Margaret M Burke
Nicholas R Banner
Ozay Halil
Peter Karran
Peter Macpherson
P304
P356
10.1182/BLOOD-2003-11-3938
P407
P577
2004-04-15T00:00:00Z